|
| 1 |
The effects of immune checkpoint modulators on the clinical course of patients with resectable hepatocellular carcinoma
Jihyun An, Hyo Jeong Kang, Eunsil Yu, Han Chu Lee, Ju Hyun Shim
|
|
| 2 |
Fatty acid synthetase expression in triple-negative breast cancer
Jin Hee Park, Hye Seung Han, So Dug Lim, Wook Youn Kim, Kyoung Sik Park, Young Bum Yoo, Seung Eun Lee, Wan-Seop Kim
|
|
| 3 |
Clinicopathologic implication of PD-L1 gene alteration in primary adrenal diffuse large B cell lymphoma
Ki Rim Lee, Jiwon Koh, Yoon Kyung Jeon, Hyun Jung Kwon, Jeong-Ok Lee, Jin Ho Paik
|
|
| 4 |
Programmed death-ligand 1 expression and tumor-infiltrating lymphocytes in non-small cell lung cancer: association with clinicopathologic parameters
Gaurav Garg, Kuruswamy Thurai Prasad, Navneet Singh, Parul Gupta, Valliappan Muthu, Ashim Das, Amanjit Bal
|
|
| 5 |
Advances in immune checkpoint inhibitors for hepatocellular carcinoma
Ji Won Han, Su-Hyung Park
J Liver Cancer.2021;21(2):139-145. Published online 2021 September 30
DOI: http://dx.doi.org/10.17998/jlc.2021.09.24
|
|
| 6 |
Cardiac Toxicities Associated with Immune Checkpoints Inhibitors: Mechanisms, Manifestations and Management
Abdulrazzak Zarifa, Jin Wan Kim, Juan Lopez-Mattei, Nicolas Palaskas, Cezar Iliescu, Peter Y. Kim
Korean Circ J.2021;51(7):579-597. Published online 2021 May 21
DOI: http://dx.doi.org/10.4070/kcj.2021.0089
|
|
| 7 |
Clinical Experience of Male Primary Choriocarcinoma at the Samsung Medical Center
Young Sok Ji, Se Hoon Park
Cancer Res Treat.2021;53(3):874-880. Published online 2020 December 7
DOI: http://dx.doi.org/10.4143/crt.2020.1066
|
|
| 8 |
Infiltration of T Cells and Programmed Cell Death Ligand 1-expressing Macrophages as a Potential Predictor of Lenvatinib Response in Hepatocellular Carcinoma
Pil Soo Sung, Sung Woo Cho, Jaejun Lee, Hyun Yang, Jeong Won Jang, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon
J Liver Cancer.2020;20(2):128-134. Published online 2020 September 30
DOI: http://dx.doi.org/10.17998/jlc.20.2.128
|
|
| 9 |
Prognostic value of programmed cell death ligand-1 expression in ovarian cancer: an updated meta-analysis
Jinlan Piao, Hyun Ji Lim, Maria Lee
|
|
| 10 |
Cancer Immunotherapy Related Endocrine Adverse Effects
Hana Kim, Sun Wook Cho, Young Joo Park
|
|
| 11 |
A Radiosensitivity Gene Signature and PD-L1 Status Predict Clinical Outcome of Patients with Glioblastoma Multiforme in The Cancer Genome Atlas Dataset
Bum-Sup Jang, In Ah Kim
Cancer Res Treat.2020;52(2):530-542. Published online 2019 November 20
DOI: http://dx.doi.org/10.4143/crt.2019.440
|
|
| 12 |
Apatinib Combined with Local Irradiation Leads to Systemic Tumor Control via Reversal of Immunosuppressive Tumor Microenvironment in Lung Cancer
Li-jun Liang, Chen-xi Hu, Yi-xuan Wen, Xiao-wei Geng, Ting Chen, Guo-qing Gu, Lei Wang, You-you Xia, Yong Liu, Jia-yan Fei, Jie Dong, Feng-hua Zhao, Yiliyar Ahongjiang, Kai-yuan Hui, Xiao-dong Jiang
Cancer Res Treat.2020;52(2):406-418. Published online 2019 September 3
DOI: http://dx.doi.org/10.4143/crt.2019.296
|
|
| 13 |
Correlation of PD-L1 Expression Tested by 22C3 and SP263 in Non-Small Cell Lung Cancer and Its Prognostic Effect on EGFR Mutation–Positive Lung Adenocarcinoma
Taehee Kim, Yoon Jin Cha, Yoon Soo Chang
|
|
| 14 |
Therapeutic Co-targeting of WEE1 and ATM Downregulates PD-L1 Expression in Pancreatic Cancer
Mei Hua Jin, Ah-Rong Nam, Ji Eun Park, Ju-Hee Bang, Yung-Jue Bang, Do-Youn Oh
Cancer Res Treat.2020;52(1):149-166. Published online 2019 June 25
DOI: http://dx.doi.org/10.4143/crt.2019.183
|
|
| 15 |
Effect of Platinum-Based Chemotherapy on PD-L1 Expression on Tumor Cells in Non-small Cell Lung Cancer
Junghoon Shin, Jin-Haeng Chung, Se Hyun Kim, Kyu Sang Lee, Koung Jin Suh, Ji Yun Lee, Ji-Won Kim, Jeong-Ok Lee, Jin-Won Kim, Yu-Jung Kim, Keun-Wook Lee, Jee Hyun Kim, Soo-Mee Bang, Jong-Seok Lee
Cancer Res Treat.2019;51(3):1086-1097. Published online 2018 November 5
DOI: http://dx.doi.org/10.4143/crt.2018.537
|
|
| 16 |
Immunohistochemistry Biomarkers Predict Survival in Stage II/III Gastric Cancer Patients: From a Prospective Clinical Trial
Min Hwan Kim, Xianglan Zhang, Minkyu Jung, Inkyung Jung, Hyung Soon Park, Seung-Hoon Beom, Hyo Song Kim, Sun Young Rha, Hyunki Kim, Yoon Young Choi, Taeil Son, Hyoung-Il Kim, Jae-Ho Cheong, Woo Jin Hyung, Sung Hoon Noh, Hyun Cheol Chung
Cancer Res Treat.2019;51(2):819-831. Published online 2018 September 27
DOI: http://dx.doi.org/10.4143/crt.2018.331
|
|
| 17 |
Immune checkpoint inhibitors for urothelial carcinoma
Hyung Suk Kim, Ho Kyung Seo
|
|
| 18 |
Prognostic Role and Clinical Association of Tumor-Infiltrating Lymphocyte, Programmed Death Ligand-1 Expression with Neutrophil-Lymphocyte Ratio in Locally Advanced Triple-Negative Breast Cancer
Jieun Lee, Dong-Min Kim, Ahwon Lee
Cancer Res Treat.2019;51(2):649-663. Published online 2018 July 31
DOI: http://dx.doi.org/10.4143/crt.2018.270
|
|
| 19 |
PD-L1 Expression on Circulating CD34+ Hematopoietic Stem Cells Closely Correlated with T-cell Apoptosis in Chronic Hepatitis C Infected Patients
Hussein Abdellatif, Gamal Shiha
|
|
| 20 |
The Major Role of NF-κB in the Depth of Invasion on Acral Melanoma by Decreasing CD8+ T Cells
Hermin Aminah Usman, Bethy S. Hernowo, Maringan Diapari Lumban Tobing, Reti Hindritiani
|
|
